Simon-Kucher's industry study reveals barriers and success factors for improving global pricing and marketing access ...

The pharmaceutical industry sits on a treasure trove of data, brimming with the potential to revolutionize drug development, enhance patient care, and optimize commercial strategies. Yet, this vast ...

Three-dimensional (3D) printing is a 20-year-old technology whose time finally seems to have arrived. Interest in the equipment rose sharply last year; in 2012, the market for 3D products reached $777 ...

Read these useful insights to answer the following questions: ...

Inozyme's CEO and chairman Douglas Treco shares his thoughts about the rousing success of the Orphan Drug Act, but cautions rare disease drug developers against sky high and inaccessible drug pricing ...

A: ZINC FINGER NUCLEASE (ZFN) TECHNOLOGIES are leading the field into in vivo human studies, and we expect other technologies will eventually catch up. Innovation in delivery technology will enable ...

The life sciences industry contributed nearly $4 billion to the U.S. economy in 2021 and is expected to continue growing an average 7% to 8% per year over the next five years. With an increasing ...

ONE OF THE MOST IMPORTANT THINGS TO DO DURING THE TRANSITION is put aside your preconceived notions and listen. We all think we know a lot about our industry partners and other components of the ...

Embracing innovative, digital transformation has allowed biopharmaceutical companies to improve manufacturing processes and quality to better benefit their clients. Samsung Biologics has been taking ...

Allan Shaw explains how the incoming Republican administration and Congress may affect the industry, including the Biosecure Act and a change of leadership for the FTC.

Built on the back of hepatocyte growth factor discoveries by Harvard Drs. Reza Dana and Sunil Chauhan, Claris Bio is rewriting the ophthalmology rulebook. CEO Clarke Atwell acknowledges that it's not ...

CEO Corner articles are written by presidents or CEOs of biopharmaceutical or medical device companies that create a drug or device. These articles discuss global industry trends, experiences, and ...